Stay updated on Tisotumab Vedotin in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Tisotumab Vedotin in Cervical Cancer Clinical Trial page.

Latest updates to the Tisotumab Vedotin in Cervical Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page’s bottom “Revision” indicator has been updated from v3.5.0 to v3.5.3, reflecting a UI/version update rather than any change to the study record content.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision metadata updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision: v3.4.2 was added, and the funding/status notice as well as Revision: v3.4.1 were removed. These are site maintenance updates that do not alter the study details or data.SummaryDifference0.3%

- Check84 days agoChange DetectedA site-wide notice about a funding lapse and the NIH Clinical Center opening status has been added, and the site revision updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

- Check91 days agoChange DetectedUI and metadata updates: a glossary toggle is now shown, and QC/FEAR Act data labels have been added or adjusted. The document revision tag has been updated to v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Tisotumab Vedotin in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin in Cervical Cancer Clinical Trial page.